OnKure Therapeutics, Inc. OKUR Private Placement Issuance Costs Included In Accrued Liabilities
Other financials
Where this comes from
Reported directly by OnKure Therapeutics, Inc. in its filing.
Tagged under the XBRL concept okur:PrivatePlacementIssuanceCostsIncludedInAccruedLiabilities.
The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s private placement issuance costs included in accrued liabilities.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s private placement issuance costs included in accrued liabilities?
- OnKure Therapeutics, Inc. (OKUR) reported private placement issuance costs included in accrued liabilities of $81K in Q1 2026.